A. Combination irinotecan (camptosar) + 5-fluorouracil + leucovorin is standard treatment for metastatic colon cancers (Dukes D, Stage IV)
B. Addition of levamisole to 5-fluorouracil and leucovorin increases survival rates ~10%
C. Adjuvant chemotherapy is standard of care for Dukes C colon cancer
D. Adjuvant therapy is not standard for Dukes B1 colon cancer
E. Survival with very early stage (Dukes A, Stage I) colon cancer is nearly normal
A. Immunotherapy with low dose interleukin 2 ± interferon alpha
B. Cisplatin ± 5-fluorouracil
C. Radiation therapy
D. High dose interleukin 2
E. Combined chemoradiotherapy
A. Responsible for ~6% of all colon cancers
B. Increased risk of endometrial cancer as well as colonic neoplasms
C. Caused by mutations in genes which code for DNA mismatch repair proteins
D. Mutations in these mismatch repair genes confer ~20% lifetime risk of colon cancer
E. Inactivation these mismatch repair genes leads to "Microsatellite Instability" (MSI)
A. Survival is >80% with amputation of limb containing the tumor
B. Five year survival with operable, non-metastatic osteosarcoma is <25%
C. Adjuvant or neoadjuvant chemotherapy improves survival to 75-80% in nonmetastatic cases
D. Multidrug regimens are significantly more effective than two drug combinations
E. Expression of multidrug resistance gene mdr1 (P glycoprotein) does not affect outcome
A. Routine use of adjuvant chemotherapy should be discouraged at this time
B. Patients with poor therapeutic responses usually die of complications of local disease
C. Risk factors include tobacco, alcohol, and nickel refining
D. Dietary carotenoids (high intake fruits and vegetables)
E. Smoking during radiation therapy has no effect on response rates
A. Chronic infection with hepatitis B and C viruses increases risk of hepatocellular cancer
B. Coinfection with hepatitis B and C viruses increases risk of developing cancer above either virus alone
C. Interferon alpha treatment of chronic viral hepatitis reduces risk of hepatocellular cancer
D. Duration of cirrhosis is not a risk factor for the development of hepatocellular cancer
E. Alcoholic cirrhosis is an additional risk factor for development of hepatocellular cancer
A. Autoimmune Thrombocytopenia
B. Hypogammaglobulinemia
C. Increased risk of bacterial, fungal, and herpes zoster infection
D. Increased secondary cancer rates (including lung and skin)
E. Transformation to Hodgkin's Lymphoma
A. Cisplatin
B. Paclitaxel (Taxol®)
C. Gemcitabine (Gemzar®)
D. Cyclophosphamide (Cytoxan®)
E. Herceptin® (anti-her2/neu monoclonal antibody, trastuzumab)
I. Most NHL in immunocompromised patients are positive for simian virus 40 (SV40) DNAII. The most accurate prognostic markers for NHL utilize the molecular (genomic) signatures of the tumor itself, rather than clinical variables or pure histopathologyIII. The majority are curable with high dose chemotherapy and stem cell rescueIV. The majority are derived from B lymphocytes rather than T lymphocytes
V. Epstein-Barr Viral DNA is virtually never found in NHL tissue
A. I, II, and III are correct
B. I and III are correct
C. II and IV are correct
D. IV is correct
E. V is correct
A. ALL is the most common form of leukemia in children
B. Most ALL cases arise from cases of chronic lymphocytic leukemia
C. Adult ALL accounts for ~30% of cases of ALL (~1000 new cases per year)
D. ALL has a high propensity for central nervous system (CNS) involvement
E. Most ALL are derived from blast phase B lymphocytes